Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy AcelRx Pharmaceuticals stock | $0.96

Learn how to easily invest in AcelRx Pharmaceuticals stock.

AcelRx Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. AcelRx Pharmaceuticals shares (ACRX) are listed on the NASDAQ and all prices are listed in US Dollars. AcelRx Pharmaceuticals employs 54 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in AcelRx Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ACRX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

AcelRx Pharmaceuticals stock price (NASDAQ: ACRX)

Use our graph to track the performance of ACRX stocks over time.

AcelRx Pharmaceuticals shares at a glance

Information last updated 2021-10-16.
Latest market close$0.96
52-week range$0.97 - $2.94
50-day moving average $1.04
200-day moving average $1.23
Wall St. target price$6.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.36

Buy AcelRx Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy AcelRx Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AcelRx Pharmaceuticals price performance over time

Historical closes compared with the close of $0.96 from 2021-10-21

1 week (2021-10-11) N/A
1 month (2021-09-18) N/A
3 months (2021-07-22) -24.41%
6 months (2021-04-22) -20.66%
1 year (2020-10-22) -48.11%
2 years (2019-10-22) -56.16%
3 years (2018-10-22) 3.75
5 years (2016-10-21) 3.2

AcelRx Pharmaceuticals financials

Revenue TTM $3.1 million
Gross profit TTM $-4,633,000
Return on assets TTM -30.31%
Return on equity TTM 0%
Profit margin 0%
Book value $-0.23
Market capitalisation $121.6 million

TTM: trailing 12 months

Shorting AcelRx Pharmaceuticals shares

There are currently 4.9 million AcelRx Pharmaceuticals shares held short by investors – that's known as AcelRx Pharmaceuticals's "short interest". This figure is 16.6% down from 5.9 million last month.

There are a few different ways that this level of interest in shorting AcelRx Pharmaceuticals shares can be evaluated.

AcelRx Pharmaceuticals's "short interest ratio" (SIR)

AcelRx Pharmaceuticals's "short interest ratio" (SIR) is the quantity of AcelRx Pharmaceuticals shares currently shorted divided by the average quantity of AcelRx Pharmaceuticals shares traded daily (recently around 676041.4266118). AcelRx Pharmaceuticals's SIR currently stands at 7.29. In other words for every 100,000 AcelRx Pharmaceuticals shares traded daily on the market, roughly 7290 shares are currently held short.

However AcelRx Pharmaceuticals's short interest can also be evaluated against the total number of AcelRx Pharmaceuticals shares, or, against the total number of tradable AcelRx Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AcelRx Pharmaceuticals's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 AcelRx Pharmaceuticals shares in existence, roughly 40 shares are currently held short) or 0.0422% of the tradable shares (for every 100,000 tradable AcelRx Pharmaceuticals shares, roughly 42 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against AcelRx Pharmaceuticals.

Find out more about how you can short AcelRx Pharmaceuticals stock.

AcelRx Pharmaceuticals share dividends

We're not expecting AcelRx Pharmaceuticals to pay a dividend over the next 12 months.

AcelRx Pharmaceuticals share price volatility

Over the last 12 months, AcelRx Pharmaceuticals's shares have ranged in value from as little as $0.97 up to $2.94. A popular way to gauge a stock's volatility is its "beta".

ACRX.US volatility(beta: 0.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AcelRx Pharmaceuticals's is 0.8772. This would suggest that AcelRx Pharmaceuticals's shares are less volatile than average (for this exchange).

AcelRx Pharmaceuticals overview

AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company's lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. It also develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006.

Frequently asked questions

What percentage of AcelRx Pharmaceuticals is owned by insiders or institutions?
Currently 1.934% of AcelRx Pharmaceuticals shares are held by insiders and 25.417% by institutions.
How many people work for AcelRx Pharmaceuticals?
Latest data suggests 54 work at AcelRx Pharmaceuticals.
When does the fiscal year end for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals's fiscal year ends in December.
Where is AcelRx Pharmaceuticals based?
AcelRx Pharmaceuticals's address is: 25821 Industrial Boulevard, Hayward, CA, United States, 94545
What is AcelRx Pharmaceuticals's ISIN number?
AcelRx Pharmaceuticals's international securities identification number is: US00444T1007
What is AcelRx Pharmaceuticals's CUSIP number?
AcelRx Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00444T100

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site